Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels.
ATP Binding Cassette Transporter, Subfamily G, Member 2
/ genetics
Cardiovascular Diseases
/ blood
Cohort Studies
Genetic Loci
Genetic Markers
Genetic Predisposition to Disease
Genome-Wide Association Study
Gout
/ blood
Hepatocyte Nuclear Factor 1-alpha
/ genetics
Hepatocyte Nuclear Factor 4
/ genetics
Humans
Kidney
/ metabolism
Liver
/ metabolism
Metabolic Diseases
/ blood
Neoplasm Proteins
/ genetics
Organ Specificity
Polymorphism, Single Nucleotide
Signal Transduction
Uric Acid
/ blood
Journal
Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
17
01
2019
accepted:
27
08
2019
pubmed:
4
10
2019
medline:
23
1
2020
entrez:
4
10
2019
Statut:
ppublish
Résumé
Elevated serum urate levels cause gout and correlate with cardiometabolic diseases via poorly understood mechanisms. We performed a trans-ancestry genome-wide association study of serum urate in 457,690 individuals, identifying 183 loci (147 previously unknown) that improve the prediction of gout in an independent cohort of 334,880 individuals. Serum urate showed significant genetic correlations with many cardiometabolic traits, with genetic causality analyses supporting a substantial role for pleiotropy. Enrichment analysis, fine-mapping of urate-associated loci and colocalization with gene expression in 47 tissues implicated the kidney and liver as the main target organs and prioritized potentially causal genes and variants, including the transcriptional master regulators in the liver and kidney, HNF1A and HNF4A. Experimental validation showed that HNF4A transactivated the promoter of ABCG2, encoding a major urate transporter, in kidney cells, and that HNF4A p.Thr139Ile is a functional variant. Transcriptional coregulation within and across organs may be a general mechanism underlying the observed pleiotropy between urate and cardiometabolic traits.
Identifiants
pubmed: 31578528
doi: 10.1038/s41588-019-0504-x
pii: 10.1038/s41588-019-0504-x
pmc: PMC6858555
mid: NIHMS1538428
doi:
Substances chimiques
ABCG2 protein, human
0
ATP Binding Cassette Transporter, Subfamily G, Member 2
0
Genetic Markers
0
HNF1A protein, human
0
HNF4A protein, human
0
Hepatocyte Nuclear Factor 1-alpha
0
Hepatocyte Nuclear Factor 4
0
Neoplasm Proteins
0
Uric Acid
268B43MJ25
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1459-1474Subventions
Organisme : Medical Research Council
ID : MC_UU_00007/10
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/13/33946
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : U01 HL120393
Pays : United States
Organisme : NHGRI NIH HHS
ID : T32 HG002295
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR073178
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL105756
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL129982
Pays : United States
Organisme : NICHD NIH HHS
ID : K12 HD043483
Pays : United States
Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL120393
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK114091
Pays : United States
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : U01 HL130114
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : P30 DK116074
Pays : United States
Références
Kuo, C. F., Grainge, M. J., Zhang, W. & Doherty, M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat. Rev. Rheumatol. 11, 649–662 (2015).
pubmed: 26150127
Li, X. et al. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ 357, j2376 (2017).
pubmed: 28592419
pmcid: 5461476
Jinno, S., Hasegawa, K., Neogi, T., Goto, T. & Dubreuil, M. Trends in emergency department visits and charges for gout in the United States between 2006 and 2012. J. Rheumatol. 43, 1589–1592 (2016).
pubmed: 27252429
pmcid: 5335867
Kuo, C. F., Grainge, M. J., Mallen, C., Zhang, W. & Doherty, M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann. Rheum. Dis. 74, 661–667 (2015).
pubmed: 24431399
Mikuls, T. R., Farrar, J. T., Bilker, W. B., Fernandes, S. & Saag, K. G. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology (Oxford) 44, 1038–1042 (2005).
Yang, Q. et al. Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. Metabolism 54, 1435–1441 (2005).
pubmed: 16253630
Vitart, V. et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat. Genet. 40, 437–442 (2008).
pubmed: 18327257
Pilia, G. et al. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2, e132 (2006).
pubmed: 16934002
pmcid: 1557782
Wang, W. et al. Heritability and genome-wide association analyses of serum uric acid in middle and old-aged Chinese twins. Front. Endocrinol. (Lausanne) 9, 75 (2018).
MacCluer, J. W. et al. Heritability of measures of kidney disease among Zuni Indians: the Zuni Kidney Project. Am. J. Kidney Dis. 56, 289–302 (2010).
pubmed: 20646805
pmcid: 3030616
Rule, A. D. et al. Genome-wide linkage analysis for uric acid in families enriched for hypertension. Nephrol. Dial. Transplant. 24, 2414–2420 (2009).
pubmed: 19258383
pmcid: 2734170
Enomoto, A. et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417, 447–452 (2002).
pubmed: 12024214
Li, S. et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet 3, e194 (2007).
pubmed: 17997608
pmcid: 2065883
Döring, A. et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat. Genet. 40, 430–436 (2008).
pubmed: 18327256
Dehghan, A. et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372, 1953–1961 (2008).
pubmed: 18834626
pmcid: 2803340
Kolz, M. et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 5, e1000504 (2009).
pubmed: 19503597
pmcid: 2683940
Yang, Q. et al. Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ. Cardiovasc. Genet. 3, 523–530 (2010).
pubmed: 20884846
pmcid: 3371395
Tin, A. et al. Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. Hum. Mol. Genet. 20, 4056–4068 (2011).
pubmed: 21768215
pmcid: 3177647
Woodward, O. M. et al. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc. Natl Acad. Sci. USA 106, 10338–10342 (2009).
pubmed: 19506252
Major, T. J., Dalbeth, N., Stahl, E. A. & Merriman, T. R. An update on the genetics of hyperuricaemia and gout. Nat. Rev. Rheumatol. 14, 341–353 (2018).
pubmed: 29740155
Köttgen, A. et al. Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat. Genet. 45, 145–154 (2013).
pubmed: 23263486
Kanai, M. et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat. Genet. 50, 390–400 (2018).
pubmed: 29403010
Schaid, D. J., Chen, W. & Larson, N. B. From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat. Rev. Genet. 19, 491–504 (2018).
pubmed: 29844615
pmcid: 6050137
Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 10, e1004383 (2014).
pubmed: 24830394
pmcid: 4022491
Kamatani, Y. et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat. Genet. 42, 210–215 (2010).
pubmed: 20139978
Okada, Y. et al. Meta-analysis identifies multiple loci associated with kidney function-related traits in east Asian populations. Nat. Genet. 44, 904–909 (2012).
pubmed: 22797727
pmcid: 4737645
Merriman, T. R. Population heterogeneity in the genetic control of serum urate. Semin. Nephrol. 31, 420–425 (2011).
pubmed: 22000648
Roddy, E. & Choi, H. K. Epidemiology of gout. Rheum. Dis. Clin. North Am. 40, 155–175 (2014).
pubmed: 24703341
pmcid: 4119792
Phipps-Green, A.J. et al. Twenty-eight loci that influence serum urate levels: analysis of association with gout. Ann. Rheum. Dis. 75, 124–130 (2016).
pubmed: 25187157
George, R.L. & Keenan, R.T. Genetics of hyperuricemia and gout: implications for the present and future. Curr. Rheumatol. Rep. 15, 309 (2013).
pubmed: 23307580
Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405–424 (2015).
pubmed: 25741868
pmcid: 25741868
Feig, D. I., Kang, D. H. & Johnson, R. J. Uric acid and cardiovascular risk. N. Engl. J. Med. 359, 1811–1821 (2008).
pubmed: 18946066
pmcid: 2684330
Keenan, T. et al. Causal assessment of serum urate levels in cardiometabolic diseases through a Mendelian randomization study. J. Am. Coll. Cardiol. 67, 407–416 (2016).
pubmed: 26821629
pmcid: 5503188
Jordan, D. M. et al. No causal effects of serum urate levels on the risk of chronic kidney disease: a Mendelian randomization study. PLoS Med. 16, e1002725 (2019).
pubmed: 30645594
pmcid: 6333326
Lyngdoh, T. et al. Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach. PLoS ONE 7, e39321 (2012).
pubmed: 22723994
pmcid: 3378571
White, J. et al. Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis. Lancet Diabetes Endocrinol. 4, 327–336 (2016).
pubmed: 26781229
pmcid: 4805857
Benner, C. et al. Prospects of fine-mapping trait-associated genomic regions by using summary statistics from genome-wide association studies. Am. J. Hum. Genet. 101, 539–551 (2017).
pubmed: 28942963
pmcid: 5630179
Wakefield, J. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am. J. Hum. Genet. 81, 208–227 (2007).
pubmed: 17668372
pmcid: 1950810
Gaulton, K. J. et al. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet. 47, 1415–1425 (2015).
pubmed: 26551672
pmcid: 26551672
Mahajan, A. et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 50, 1505–1513 (2018).
pubmed: 30297969
pmcid: 6287706
Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493–1501 (2016).
pubmed: 26773131
pmcid: 4866522
Pao, S. S., Paulsen, I. T. & Saier, M. H. Jr. Major facilitator superfamily. Microbiol. Mol. Biol. Rev. 62, 1–34 (1998).
pubmed: 9529885
pmcid: 98904
Asano, T. et al. The role of N-glycosylation of GLUT1 for glucose transport activity. J. Biol. Chem. 266, 24632–24636 (1991).
pubmed: 1761560
Boyle, E. A., Li, Y. I. & Pritchard, J. K. An expanded view of complex traits: from polygenic to omnigenic. Cell 169, 1177–1186 (2017).
pubmed: 5536862
pmcid: 5536862
Prestin, K. et al. Regulation of PDZ domain-containing 1 (PDZK1) expression by hepatocyte nuclear factor-1α (HNF1α) in human kidney. Am. J. Physiol. Renal Physiol. 313, F973–F983 (2017).
pubmed: 28724612
Maher, J. M. et al. Alterations in transporter expression in liver, kidney, and duodenum after targeted disruption of the transcription factor HNF1α. Biochem. Pharmacol. 72, 512–522 (2006).
pubmed: 16806085
Sulem, P. et al. Identification of low-frequency variants associated with gout and serum uric acid levels. Nat. Genet. 43, 1127–1130 (2011).
pubmed: 21983786
Togawa, N., Miyaji, T., Izawa, S., Omote, H. & Moriyama, Y. A Na
pubmed: 22460716
Kirby, A. et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat. Genet. 45, 299–303 (2013).
pubmed: 23396133
pmcid: 3901305
Kraus, M. R. et al. Two mutations in human BICC1 resulting in Wnt pathway hyperactivity associated with cystic renal dysplasia. Hum. Mutat. 33, 86–90 (2012).
pubmed: 21922595
Hart, T. C. et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J. Med. Genet. 39, 882–892 (2002).
pubmed: 12471200
pmcid: 1757206
Sodini, S. M., Kemper, K. E., Wray, N. R. & Trzaskowski, M. Comparison of genotypic and phenotypic correlations: Cheverud’s conjecture in humans. Genetics 209, 941–948 (2018).
pubmed: 29739817
pmcid: 6028255
Lindgren, D. et al. Cell-type-specific gene programs of the normal human nephron define kidney cancer subtypes. Cell Rep. 20, 1476–1489 (2017).
pubmed: 28793269
Prestin, K. et al. Transcriptional regulation of urate transportosome member SLC2A9 by nuclear receptor HNF4α. Am. J. Physiol. Renal Physiol. 307, F1041–F1051 (2014).
pubmed: 25209865
Ketharnathan, S. et al. A non-coding genetic variant maximally associated with serum urate levels is functionally linked to HNF4A-dependent PDZK1 expression. Hum. Mol. Genet. 27, 3964–3973 (2018).
pubmed: 30124855
Marable, S. S., Chung, E., Adam, M., Potter, S. S. & Park, J. S. Hnf4a deletion in the mouse kidney phenocopies Fanconi renotubular syndrome. JCI Insight 3, 97497 (2018).
pubmed: 30046000
Matsuo, H. et al. ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload. Sci. Rep. 4, 3755 (2014).
pubmed: 24441388
pmcid: 3895923
Daigo, K. et al. Proteomic analysis of native hepatocyte nuclear factor-4α (HNF4α) isoforms, phosphorylation status, and interactive cofactors. J. Biol. Chem. 286, 674–686 (2011).
pubmed: 21047794
Chandra, V. et al. Multidomain integration in the structure of the HNF-4α nuclear receptor complex. Nature 495, 394–398 (2013).
pubmed: 23485969
pmcid: 3606643
Zhu, Q. et al. T130I mutation in HNF-4α gene is a loss-of-function mutation in hepatocytes and is associated with late-onset Type 2 diabetes mellitus in Japanese subjects. Diabetologia 46, 567–573 (2003).
pubmed: 12669197
Heinz, L. X. et al. The death domain-containing protein Unc5CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascade. Cell Death Differ. 19, 722–731 (2012).
pubmed: 22158417
Saxena, R. et al. Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci. Am. J. Hum. Genet. 90, 410–425 (2012).
pubmed: 22325160
pmcid: 3309185
Kooner, J. S. et al. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat. Genet. 43, 984–989 (2011).
pubmed: 21874001
pmcid: 21874001
Van Gennip, A. H., Van Bree-Blom, E. J., Grift, J., DeBree, P. K. & Wadman, S. K. Urinary purines and pyrimidines in patients with hyperammonemia of various origins. Clin. Chim. Acta 104, 227–239 (1980).
pubmed: 6771064
Pattaro, C. et al. Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat. Commun. 7, 10023 (2016).
pubmed: 26831199
pmcid: 4735748
van Meurs, J. B. et al. Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am. J. Clin. Nutr. 98, 668–676 (2013).
pubmed: 23824729
pmcid: 4321227
Raffler, J. et al. Genome-wide association study with targeted and non-targeted NMR metabolomics identifies 15 novel loci of urinary human metabolic individuality. PLoS Genet. 11, e1005487 (2015).
pubmed: 26352407
pmcid: 4564198
Beer, N. L. et al. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum. Mol. Genet. 18, 4081–4088 (2009).
pubmed: 19643913
pmcid: 2758140
McCarthy, S. et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat. Genet. 48, 1279–1283 (2016).
pubmed: 27548312
pmcid: 27548312
Abecasis, G. R. et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012).
pubmed: 23128226
pmcid: 23128226
Fuchsberger, C., Taliun, D., Pramstaller, P. P. & Pattaro, C. GWAtoolbox: an R package for fast quality control and handling of genome-wide association studies meta-analysis data. Bioinformatics 28, 444–445 (2012).
pubmed: 22155946
Marchini, J. & Howie, B. Genotype imputation for genome-wide association studies. Nat. Rev. Genet. 11, 499–511 (2010).
pubmed: 20517342
Haller, T., Kals, M., Esko, T., Mägi, R. & Fischer, K. RegScan: a GWAS tool for quick estimation of allele effects on continuous traits and their combinations. Brief. Bioinform. 16, 39–44 (2015).
pubmed: 24008273
Zhan, X., Hu, Y., Li, B., Abecasis, G. R. & Liu, D. J. RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data. Bioinformatics 32, 1423–1426 (2016).
pubmed: 27153000
pmcid: 4848408
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
pubmed: 25722852
pmcid: 4342193
Aulchenko, Y. S., Struchalin, M. V. & van Duijn, C. M. ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics 11, 134 (2010).
pubmed: 20233392
pmcid: 2846909
Chen, M. H. & Yang, Q. GWAF: an R package for genome-wide association analyses with family data. Bioinformatics 26, 580–581 (2010).
pubmed: 20040588
Zhou, X. & Stephens, M. Genome-wide efficient mixed-model analysis for association studies. Nat. Genet. 44, 821–824 (2012).
pubmed: 22706312
pmcid: 3386377
Li, Y., Willer, C. J., Ding, J., Scheet, P. & Abecasis, G. R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816–834 (2010).
pubmed: 21058334
pmcid: 21058334
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
pubmed: 20616382
pmcid: 2922887
Devlin, B., Roeder, K. & Wasserman, L. Genomic control, a new approach to genetic-based association studies. Theor. Popul. Biol. 60, 155–166 (2001).
pubmed: 11855950
Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539–1558 (2002).
pubmed: 12111919
pmcid: 12111919
Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630
pmcid: 4495769
Hadfield, J. D. MCMC methods for multi-response generalized linear mixed models: the MCMCglmm R Package. J. Stat. Softw. 33, 1–22 (2010).
Pattaro, C. et al. The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results. J. Transl. Med. 13, 348 (2015).
pubmed: 26541195
pmcid: 4635524
Noce, D. et al. Sequential recruitment of study participants may inflate genetic heritability estimates. Hum. Genet. 136, 743–757 (2017).
pubmed: 28374192
Mägi, R. et al. Trans-ethnic meta-regression of genome-wide association studies accounting for ancestry increases power for discovery and improves fine-mapping resolution. Hum. Mol. Genet. 26, 3639–3650 (2017).
pubmed: 28911207
pmcid: 5755684
Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
pubmed: 25826379
pmcid: 4380465
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
pubmed: 26414676
pmcid: 4797329
Zheng, J. et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 33, 272–279 (2017).
pubmed: 27663502
pmcid: 27663502
O’Connor, L. J. & Price, A. L. Distinguishing genetic correlation from causation across 52 diseases and complex traits. Nat. Genet. 50, 1728–1734 (2018).
pubmed: 30374074
pmcid: 6684375
Pers, T. H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015).
pubmed: 25597830
pmcid: 4420238
Frey, B. J. & Dueck, D. Clustering by passing messages between data points. Science 315, 972–976 (2007).
pubmed: 17218491
Bodenhofer, U., Kothmeier, A. & Hochreiter, S. APCluster: an R package for affinity propagation clustering. Bioinformatics 27, 2463–2464 (2011).
pubmed: 21737437
Wuttke, M. et al. A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat. Genet. 51, 957–972 (2019).
pubmed: 31152163
pmcid: 6698888
Sheffield, N. C. et al. Patterns of regulatory activity across diverse human cell types predict tissue identity, transcription factor binding, and long-range interactions. Genome Res. 23, 777–788 (2013).
pubmed: 23482648
pmcid: 3638134
Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
pubmed: 25693563
pmcid: 4530010
Arnold, M., Raffler, J., Pfeufer, A., Suhre, K. & Kastenmüller, G. SNiPA: an interactive, genetic variant-centered annotation browser. Bioinformatics 31, 1334–1336 (2015).
pubmed: 25431330
Dong, C. et al. Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies. Hum. Mol. Genet. 24, 2125–2137 (2015).
pubmed: 25552646
Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310–315 (2014).
pubmed: 24487276
pmcid: 3992975
Li, J. et al. Performance evaluation of pathogenicity-computation methods for missense variants. Nucleic Acids Res. 46, 7793–7804 (2018).
pubmed: 30060008
pmcid: 6125674
Gillies, C. E. et al. An eQTL landscape of kidney tissue in human nephrotic syndrome. Am. J. Hum. Genet. 103, 232–244 (2018).
pubmed: 30057032
pmcid: 6081280
Lonsdale, J. et al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585 (2013).
Ko, Y. A. et al. Genetic-variation-driven gene-expression changes highlight genes with important functions for kidney disease. Am. J. Hum. Genet. 100, 940–953 (2017).
pubmed: 28575649
pmcid: 5473735
Khan, A. et al. JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. 46, D1284 (2018).
pubmed: 29161433
Sandelin, A., Alkema, W., Engström, P., Wasserman, W. W. & Lenhard, B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32, D91–D94 (2004).
pubmed: 14681366
pmcid: 308747
Xie, Y. et al. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells. Biochim. Biophys. Acta 1849, 317–327 (2015).
pubmed: 25615818
pmcid: 4336604
Lee, C. & Huang, C. H. LASAGNA-Search 2.0: integrated transcription factor binding site search and visualization in a browser. Bioinformatics 30, 1923–1925 (2014).
pubmed: 24578403
Vesuna, F., Winnard, P. Jr. & Raman, V. Enhanced green fluorescent protein as an alternative control reporter to Renilla luciferase. Anal. Biochem. 342, 345–347 (2005).
pubmed: 15950916
pmcid: 1974853